E7080
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for E7080, covering 2015-02-16 to 2021-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) [Phase 1, Phase 2]